# Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension

> **NCT01915940** · PHASE2 · COMPLETED · sponsor: **ForSight Vision5, Inc.** · enrollment: 169 (actual)

## Conditions studied

- Primary Open-Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Bimatoprost
- **DRUG:** Timolol 0.5%
- **DRUG:** Placebo Eye Drops
- **DEVICE:** Placebo Ocular Insert

## Key facts

- **NCT ID:** NCT01915940
- **Lead sponsor:** ForSight Vision5, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10-23
- **Primary completion:** 2014-09-30
- **Final completion:** 2014-11-14
- **Target enrollment:** 169 (ACTUAL)
- **Last updated:** 2018-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01915940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01915940, "Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01915940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*